1X10^6 PHA-stimulated (5 μg/mL, overnight) human peripheral blood mononuclear cells (PBMCs) were surface stained with 0.20 ug CoraLite647-conjugated Anti-Human PD-1/CD279 (CL647-66220, clone: 4H4D1) and 0.20 ug FITC-Anti-Human CD3 (FITC-65151, clone UCHT1). Cells were not fixed.
Immunofluorescent analysis of (4% PFA) fixed human tonsillitis tissue using CoraLite®647 PD-1/CD279 antibody (CL647-66220, Clone: 4H4D1 ) at dilution of 1:100.
Immunofluorescent analysis of (4% PFA) fixed human tonsillitis tissue using CoraLite®647 PD-1/CD279 antibody (CL647-66220, Clone: 4H4D1 ) at dilution of 1:100.
1X10^6 human peripheral blood mononuclear cells (PBMCs) were surface stained with 0.20 ug CoraLite647-conjugated Anti-Human PD-1/CD279 (CL647-66220, clone: 4H4D1) and 0.20 ug FITC-Anti-Human CD3 (FITC-65151, clone UCHT1). Cells were not fixed.
Immunofluorescent analysis of (4% PFA) fixed human tonsillitis tissue using CoraLite®647 PD-1/CD279 antibody (CL647-66220, Clone: 4H4D1 ) at dilution of 1:200, CoraLite®594 CD11c/Integrin Alpha X antibody (CL594-60258, Clone: 2F1C10, red), CoraLite®488 CD8 antibody (CL488-66868, Clone: 1G2B10, green).